Informa Markets Korea has opened pre-registration for CPHI/Hi Korea 2026, scheduled to take place at COEX, Seoul, from August 25–27.
The event is expected to bring together more than 420 companies from over 70 countries, showcasing the latest ingredients, products, and technology solutions to an anticipated audience of over 12,000 industry professionals.
The exhibition has secured support from major government and industry bodies, including the Ministry of Food and Drug Safety (MFDS), Korea Fund for Regenerative Medicine (KFRM), Korea Institute of Toxicology (KIT), Korea Health Functional Food Association (KHFF), Korea Drug Research Association (KDRA), Korea Invention Promotion Association (KIPA), and DIPS. The Bio Zone will be co-organized with the Korea Biomedicine Industry Association (KoBIA).
Reflecting growing industry engagement, this year’s conference programme has expanded from four tracks to six, offering broader industry coverage. Building on last year’s momentum, the K-Health Conference will include MFDS-led discussions on regulations for personalized health functional foods.
Dedicated bio and pharma sessions will highlight Korea’s emerging K-platform technologies, including antibody-drug conjugates (ADC), targeted protein degradation (TPD), radiopharmaceutical therapy (RPT), and clinical trials, alongside updates on GLP-1 developments.
The programme will also feature the Biohealth Policy Forum hosted by KDRA, focusing on industry policy direction and strategic priorities.
Additional activities include IR sessions, a Startup Challenge, and the Global Build-Up Program, aimed at supporting commercialization and market expansion into Japan, China, Thailand, Malaysia, and the United States.
Pre-registration is now open: https://cphik.imasia-passport.com/bn50eD
